Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 600 of 1863 entries
View as:

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

Phase: N/A Priority: Normal
NCT ID: NCT05296304 Org: User:
Start: 03/16/22 End: 03/31/26 Due: 03/31/27

A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05574127 Org: User:
Start: 10/06/22 End: 06/01/26 Due: 06/01/27

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04751435 Org: User:
Start: 11/16/21 End: 08/31/26 Due: 08/31/27

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00002558 Org: User:
Start: 01/31/94 End: 04/30/09 Due: 04/30/10

Testing a New Imaging Agent to Identify Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04692831 Org: User:
Start: 11/30/20 End: 11/30/26 Due: 11/30/27

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT06305741 Org: User:
Start: 03/05/24 End: 03/31/26 Due: 03/31/27

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06377566 Org: User:
Start: 04/17/24 End: 04/30/27 Due: 04/30/28

Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain

Phase: N/A Priority: Normal
NCT ID: NCT03523351 Org: User:
Start: 05/01/18 End: 04/18/24 Due: 04/18/25

Clinical and Histopathologic Characteristics of BAP1 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT01773655 Org: User:
Start: 01/31/13 End: 06/30/20 Due: 06/30/21

A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03122522 Org: User:
Start: 04/17/17 End: 04/30/26 Due: 04/30/27

A Study of Emapalumab for Pediatric Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT06430788 Org: User:
Start: 05/21/24 End: 05/21/29 Due: 05/21/30

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02136797 Org: User:
Start: 05/08/14 End: 02/08/24 Due: 02/08/25

Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00972036 Org: User:
Start: 08/31/09 End: 12/31/14 Due: 12/31/15

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02932280 Org: User:
Start: 10/31/16 End: 10/31/25 Due: 10/31/26

DNA Repair and Genetic Susceptibility to Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00611598 Org: User:
Start: 02/11/03 End: 03/24/23 Due: 03/24/24

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05429320 Org: User:
Start: 06/15/22 End: 06/15/26 Due: 06/15/27

Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02530177 Org: User:
Start: 08/19/15 End: 08/31/26 Due: 08/31/27

A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00421512 Org: User:
Start: 03/31/06 End: 05/31/08 Due: 05/31/09

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02833883 Org: User:
Start: 07/31/16 End: 01/13/23 Due: 01/13/24

A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00610285 Org: User:
Start: 10/31/05 End: 07/31/10 Due: 07/31/11

Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification

Phase: N/A Priority: Normal
NCT ID: NCT02177175 Org: User:
Start: 06/24/14 End: 06/24/21 Due: 06/24/22

T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00002718 Org: User:
Start: 11/30/95 End: 10/31/08 Due: 10/31/09

Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04916249 Org: User:
Start: 05/28/21 End: 05/28/26 Due: 05/28/27

Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00250978 Org: User:
Start: 11/30/05 End: 04/30/08 Due: 04/30/09

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Phase: N/A Priority: Normal
NCT ID: NCT06780176 Org: User:
Start: 01/13/25 End: 01/13/30 Due: 01/13/31